サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1747285

血球因子市場：製品タイプ別、ソース別、用途別、投与経路別、エンドユーザー別、地域別

Blood Cell Factors Market, By Product Type, By Source, By Application, By Route of Administration, By End user, By Geography

出版日
ページ情報
英文 140 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.36円
血球因子市場：製品タイプ別、ソース別、用途別、投与経路別、エンドユーザー別、地域別
出版日: 2025年05月19日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血球因子の世界市場は、2025年には33億7,000万米ドルと推定され、2032年までには43億1,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR3.6%で成長する見込みです。

レポート範囲 レポート詳細
基準年 2024年 2025年の市場規模 33億7,000万米ドル
実績データ 2020年～2024年 予測期間 2025年～2032年
予測期間：2025年～2032年 CAGR： 3.60% 2032年の金額予測 43億1,000万米ドル

世界の血球因子市場は、さまざまな血液疾患の治療と管理において重要な役割を果たす、ヘルスケア産業の重要な構成要素として浮上してきました。血球因子は、赤血球、白血球、血小板を含む血球因子の成長、分化、機能を調節する必須タンパク質および分子です。これらの因子は、貧血、白血病、血小板減少症など、血液に関連するさまざまな疾患の治療に役立つ可能性があるため、近年大きな注目を集めています。血球因子の市場は、血液疾患の有病率の増加、バイオテクノロジーと製薬研究の進歩、効果的で的を絞った治療に対する需要の高まりによって牽引されています。本稿では、世界の血球因子市場を包括的に概観し、その現状、主な促進要因・課題、将来展望を明らかにすることを目的とします。

市場力学：

世界の血球因子市場は、いくつかの主要促進要因、市場抑制要因、および機会によって影響を受けます。主な促進要因の1つは、貧血、白血病、リンパ腫などの血液疾患の世界の発生率の上昇です。これらの疾患の有病率の増加は、血球因子を含む効果的な治療に対する大きな需要を生み出しています。さらに、血液関連疾患に罹患しやすい高齢化人口の増加が、市場の成長をさらに促進しています。バイオテクノロジーと製薬研究の進歩も、新規の標的治療薬の開発を可能にし、市場牽引に重要な役割を果たしています。しかし、研究開発コストの高さ、規制要件の厳しさ、血球因子療法に伴う副作用の可能性といった市場抑制要因もあります。これらの課題は、これらの治療の普及と利用しやすさの妨げとなる可能性があります。こうした市場抑制要因にもかかわらず、市場には成長と技術革新の大きな機会があります。個別化医療への注目の高まり、バイオシミラーの市場開拓、新興経済諸国におけるヘルスケアインフラの拡充は、市場関係者にとって新たな道を切り開くものと期待されます。さらに、製薬企業、研究開発機関、政府機関の連携により、血球因子療法の市場開拓と商業化が加速し、今後の市場成長を牽引するとみられます。

本調査の主な特徴

  • 本レポートでは、世界の血球因子市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
  • また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の血球因子市場の主要企業をプロファイルしています。
  • 本レポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
  • 世界の血球因子市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
  • 利害関係者は、世界の血球因子市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界の血球因子市場、製品タイプ別、2020年～2032年

  • エリスロポエチン刺激剤（ESA）
  • 顆粒球コロニー刺激因子（G-CSF）
  • 顆粒球マクロファージコロニー刺激因子（GM-CSF）
  • トロンボポエチン受容体作動薬
  • 幹細胞因子
  • その他の血球因子（例：インターロイキン）

第5章 世界の血球因子市場、ソース別、2020年～2032年

  • 組み換え（rDNA技術由来）
  • 天然（血漿由来）

第6章 世界の血球因子市場、用途別、2020年～2032年

  • 腫瘍学
  • 腎臓学
  • 血液疾患
  • 感染症
  • 自己免疫疾患
  • その他（例：HIV関連貧血）

第7章 世界の血球因子市場、投与経路別、2020年～2032年

  • 注射剤
  • 経口

第8章 世界の血球因子市場、エンドユーザー別、2020年～2032年

  • 病院
  • 外来手術センター
  • 在宅ヘルスケア
  • 専門クリニック
  • 研究・学術機関
  • その他

第9章 世界の血球因子市場、地域別、2020年～2032年

  • 北米
      • 米国
      • カナダ
  • ラテンアメリカ
      • ブラジル
      • アルゼンチン
      • メキシコ
      • その他ラテンアメリカ
  • 欧州
      • ドイツ
      • 英国
      • スペイン
      • フランス
      • イタリア
      • ロシア
      • その他欧州
  • アジア太平洋
      • 中国
      • インド
      • 日本
      • オーストラリア
      • 韓国
      • ASEAN
      • その他アジア太平洋
  • 中東
      • GCC諸国
      • イスラエル
      • その他中東
  • アフリカ
      • 南アフリカ
      • 北アフリカ
      • 中央アフリカ

第10章 競合情勢

  • Amgen Inc.
  • Johnson & Johnson
  • Roche Holding AG
  • Novartis AG
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Celgene Corporation
  • Takeda Pharmaceutical Company Limited
  • Regeneron Pharmaceuticals, Inc.

第11章 アナリストの提言

  • 運命の輪
  • アナリストの見解
  • Coherent Opportunity Map

第12章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI7942

Global Blood Cell Factors Market is estimated to be valued at USD 3.37 Bn in 2025 and is expected to reach USD 4.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.37 Bn
Historical Data for: 2020 to 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 3.60% 2032 Value Projection: USD 4.31 Bn

The global blood cell factors market has emerged as a critical component of the healthcare industry, playing a vital role in the treatment and management of various hematological disorders. Blood cell factors are essential proteins and molecules that regulate the growth, differentiation, and function of blood cells, including red blood cells, white blood cells, and platelets. These factors have gained significant attention in recent years due to their potential in treating a wide range of blood-related diseases, such as anemia, leukemia, and thrombocytopenia. The market for blood cell factors is driven by the increasing prevalence of hematological disorders, advancements in biotechnology and pharmaceutical research, and the growing demand for effective and targeted therapies. This article aims to provide a comprehensive overview of the global blood cell factors market, highlighting its current state, key drivers, challenges, and future prospects.

Market Dynamics:

The global blood cell factors market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the rising incidence of hematological disorders worldwide, such as anemia, leukemia, and lymphoma. The increasing prevalence of these diseases has created a significant demand for effective treatments, including blood cell factors. Additionally, the growing aging population, which is more susceptible to blood-related disorders, has further fueled the market growth. Advancements in biotechnology and pharmaceutical research have also played a crucial role in driving the market, enabling the development of novel and targeted therapies. However, the market also faces certain restraints, such as the high cost of research and development, stringent regulatory requirements, and the potential side effects associated with blood cell factor therapies. These challenges can hinder the adoption and accessibility of these treatments. Despite these restraints, the market presents significant opportunities for growth and innovation. The increasing focus on personalized medicine, the development of biosimilars, and the expansion of healthcare infrastructure in emerging economies are expected to create new avenues for market players. Moreover, collaborations between pharmaceutical companies, research institutions, and government organizations are likely to accelerate the development and commercialization of blood cell factor therapies, thereby driving market growth in the coming years.

Key features of the study:

  • This report provides in-depth analysis of the global blood cell factors market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global blood cell factors market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Amgen Inc., Johnson & Johnson, Roche Holding AG, Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., Sanofi S.A., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Celgene Corporation, Takeda Pharmaceutical Company Limited, and Regeneron Pharmaceuticals, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global blood cell factors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood cell factors market.

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Erythropoietin Stimulating Agents (ESAs)
    • Granulocyte Colony-Stimulating Factor (G-CSF)
    • Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
    • Thrombopoietin Receptor Agonists
    • Stem Cell Factor
    • Other Blood Cell Factors (e.g. Interleukins)
  • Source Insights (Revenue, USD Bn, 2020 - 2032)
    • Recombinant (rDNA technology-derived)
    • Natural (Plasma-derived)
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Oncology
    • Nephrology
    • Hematology Disorders
    • Infectious Diseases
    • Autoimmune Disorders
    • Others (e.g., HIV-related anemia)
  • Route Of Administration Insights (Revenue, USD Bn, 2020 - 2032)
    • Injectable
    • Oral
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Ambulatory Surgical Centers
    • Home Healthcare
    • Specialty Clinics
    • Research & Academic Institutes
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Amgen Inc.
    • Johnson & Johnson
    • Roche Holding AG
    • Novartis AG
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Gilead Sciences, Inc.
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc.
    • Celgene Corporation
    • Takeda Pharmaceutical Company Limited
    • Regeneron Pharmaceuticals, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Blood Cell Factors Market, By Product Type
    • Global Blood Cell Factors Market, By Source
    • Global Blood Cell Factors Market, By Application
    • Global Blood Cell Factors Market, By Route of Administration
    • Global Blood Cell Factors Market, By End user
    • Global Blood Cell Factors Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Blood Cell Factors Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Erythropoietin Stimulating Agents (ESAs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Granulocyte Colony-Stimulating Factor (G-CSF)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Thrombopoietin Receptor Agonists
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Stem Cell Factor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Blood Cell Factors (e.g. Interleukins)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Blood Cell Factors Market, By Source, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Recombinant (rDNA technology-derived)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Natural (Plasma-derived)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Blood Cell Factors Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nephrology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hematology Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Autoimmune Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (e.g., HIV-related anemia)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Blood Cell Factors Market, By Route of Administration, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Blood Cell Factors Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Home Healthcare
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research & Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Blood Cell Factors Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche Holding AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Gilead Sciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Celgene Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takeda Pharmaceutical Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Regeneron Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us